MAIN MENU
QUICK LINKS
CONNECT WITH US

Button

Clinical Trial Details

Title
GS-US-384-1943: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
Study Description

The purpose of this study is to see if selonsertib is safe, well tolerated, and whether can reduce fibrosis and associated complications in subjects with cirrhosis fibrosis due to NASH.

Investigators

Sub Investigator
James S. Scolapio, M.D.
Medicine